Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Quantum Genomics | 2QG | 16. mai 2024 | 0.12 | +0.50 |
RECCE PHARMACEUTICALS Ordinary Fully Paid (Australia) | R9Q | 16. mai 2024 | 0.34 | -2.29 |
Redx Pharma Plc | 0RX | 16. mai 2024 | 0.17 | 0.00 |
RemeGen Co. Ltd. | REG | 16. mai 2024 | 3.64 | +3.41 |
ReproCELL Incorporated | 6RC | 16. mai 2024 | 0.57 | -1.71 |
Ryvu Therapeutics S.A. | 9Y4 | 16. mai 2024 | 12.24 | +3.03 |
Sareum Holdings Plc | RYH0 | 16. mai 2024 | 0.43 | -5.29 |
Scancell Hldgs Plc | SCP | 16. mai 2024 | 0.10 | +16.36 |
Sensorion | RFM | 16. mai 2024 | 0.69 | +1.47 |
Shanghai Haohai Biological Technology Co. Ltd | 5HB | 16. mai 2024 | 4.90 | +0.41 |
Silence Therapeutics Plc - American Depository Share | XRP2 | 16. mai 2024 | 19.50 | +5.41 |
Simcere Pharmaceutical Group Limited | S2P | 16. mai 2024 | 0.65 | -1.52 |
SINO BIOPHARM | SMZ1 | 16. mai 2024 | 0.36 | +1.58 |
SkinBioTherapeutics Plc | 5KW | 16. mai 2024 | 0.10 | +18.75 |
Sosei Group Corp. | JSS | 16. mai 2024 | 8.85 | +1.14 |
Starpharma Holdings Ltd. | PQ6 | 16. mai 2024 | 0.06 | -12.88 |
Synairgen | OMY | 16. mai 2024 | 0.05 | +1.89 |
Takara Bio Inc. | TF2 | 16. mai 2024 | 6.20 | +1.64 |
Theranexus SA | 3VG | 16. mai 2024 | 1.03 | -1.44 |
UCB SA | UNC0 | 16. mai 2024 | 60.50 | +2.54 |
Valbiotis SA | 8JD | 16. mai 2024 | 4.30 | -0.35 |
Valirx Plc | EAJF | 16. mai 2024 | 0.02 | -28.57 |
Vaxcyte, Inc. | 5VA | 16. mai 2024 | 65.50 | +5.65 |
Viva Biotech Holdings Ordinary Shares (Cayman Islands) | VB0 | 16. mai 2024 | 0.07 | +2.84 |
Wuxi Biologics (Cayman) Inc American Depositary Receipts - U | 1FW1 | 16. mai 2024 | 3.30 | +1.23 |
Wuxi Biologics (Cayman) Inc. | 1FW2 | 16. mai 2024 | 1.73 | +2.38 |
Zelira Therapeutics Limited | G1G | 16. mai 2024 | 0.29 | -1.38 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.